PFE Pfizer Inc.

27.54USD-1.85%Mkt Cap: 156.97B USDP/E: 39.34

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The co…

Institutional holders20 on file

Key Statistics

Company
Market Cap156.97B USD
Enterprise Value209.37B USD
Revenue (TTM)63.62B USD
Gross Profit46.51B USD
Net Income (TTM)7.77B USD
Revenue/Share11.17 USD
Last Price27.54 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees75.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)39.34
P/E (Forward)9.32
PEG8.56
EV/EBITDA8.40
EV/Revenue3.29
P/S2.47
P/B1.76
EPS (TTM)0.70 USD
EPS (Forward)2.95 USD
52W Range
23.6250% of range31.44
52W High31.44 USD
52W Low23.62 USD
Profitability
Gross Margin74.33%
Oper. Margin29.07%
EBITDA Margin39.19%
Profit Margin12.42%
ROE8.99%
ROA3.73%
ROIC12.69%
ROCE10.17%
Growth
Revenue Growth-0.40%
Earnings Growth-9.70%
Cash Flow & Leverage
Operating CF11.70B USD
CapEx (TTM)2.63B USD
FCF Margin20.44%
FCF Yield8.29%
Net Debt49.13B USD
Net Debt/EBITDA1.97
Net Debt/FCF3.78
Balance Sheet
Debt/Equity0.74
Current Ratio1.42
Quick Ratio1.00
Book Value/Sh15.61 USD
Cash/Share2.50 USD
Dividends
Fwd Div Rate1.72 USD
Trail. Div Rate2.15 USD
Div. Yield6.13%
5Y Avg Yield4.82%
Payout Ratio245.71%
Ex-Div DateNov 6, 2026
Pay DateDec 7, 2026
Splits
Last Split1054:1000
Split DateNov 17, 2020
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.22 USD
Upside (mean)+9.7%
Target Range25.00 USD – 37.00 USD
25.00+9.7% to mean37.00
# Analysts26
Ownership
Shares Out.5.70B
Float5.69B
Insiders0.13%
Institutions69.75%
Short Interest
Short Ratio4.5d
Short % Float2.36%
Short % Out.2.36%
Shares Short134.42M
Short (prev mo.)150.22M
Technical
SMA 5028.81 (-4.4%)
SMA 20027.00 (+2.0%)
Beta0.30
S&P 52W Chg12.08%
Avg Vol (30d)31.01M
Avg Vol (10d)39.98M
Technical Indicators
RSI (14)33.5
MACD-0.2358
MACD Signal0.0577
MACD Hist.-0.2935
BB Upper31.13 USD
BB Middle29.45 USD
BB Lower27.77 USD
BB Width11.40%
ATR (14)0.6658 USD
Vol Ratio (20d)1.03x

About Pfizer (NYSE: PFE)

›

Pfizer (NYSE: PFE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector, and reports about 75,000 employees.

The shares were at 27.54 USD on 19 November 2026, up 13.6% over 52 weeks. Its 52-week range is 23.62 USD to 31.44 USD: the price is 12.4% below the high and 16.6% above the low.

At a market capitalisation of 156.97B USD, it trades at 39.3 times trailing earnings and 9.3 times forward earnings. The median trailing P/E of its 19 largest Drug Manufacturers - General peers is 25.4, a premium of 55% for PFE. It pays a dividend yielding 6.13% (it pays out 246% of its earnings), against a median of 2.43% among the dividend payers in that peer group.

Pfizer reports return on equity of 9.0%, an operating margin of 29.1% and flat revenue year over year.

Its debt exceeds its cash by 49.13B USD, a debt-to-equity ratio of 0.74. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 26 analysts cover the stock, with an average rating of Hold; their mean price target of 30.22 USD is 9.7% above the current price. The next earnings report is expected on 2 February 2027.